|
Highlights |
- Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis
Treatment with non-anthracycline (ANT)-based chemotherapy has increased survival in patients with extranodal natural killer/T-cell lymphoma (ENKTCL). However, the relative efficacy of various drug combinations has been contentious.
Read More >> - Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is a heterogenous hematological disorder with malignant potential controlled by immunological characteristics of the tumor microenvironment. Rapid breakthrough in the molecular pathways has made immunological approaches the main anchor in the management of DLBCL, with or without chemotherapeutic agents.
Read More >> - Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy. ICI therapy is generally better tolerated than cytotoxic chemotherapy; however, hematological adverse events (AEs) have not been fully analyzed.
Read More >> - Mature Type T-Lymphoblastic Leukemia/Lymphoma Presenting With Isolated Central Nervous System Symptomatology in a Patient With Giant Cell Arteritis on Long-Term Steroid Treatment
T-lymphoblastic leukemia/lymphoma (T-ALL/T-LBL) is a malignancy comprised of T-lymphoblasts that can present as one of four clinical subtypes (pro-T, pre-T, cortical T, and mature T).
Read More >> - Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies
Acute myeloid leukemia (AML) arising from myeloproliferative neoplasms (MPNs) represents a small subtype of secondary AML (sAML). This entity is well known to be associated with poor responses to available treatment options and dismal outcomes.
Read More >>
Featured |
|
| Featured |
|
| Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia |
Key Clinical Image |
![]() Sickle Cell Trait: Is It Always Benign? |
Current Issue |
|
Vol. 12, No. 5, Oct 2023
Table of Contents
Original Article
The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning | Abstract HTML PDF |
Sorana G. Ursu![]() |
201-207 |
doi: https://doi.org/10.14740/jh1148 |
Validation of the New MINI-CUBE for Clinic Determination of Erythrocyte Sedimentation Rate | Abstract HTML PDF Suppl1 |
Flaminia Tomassetti, Martina Pelagalli, Eleonora Nicolai, Serena Sarubbi, Cinzia Calabrese, Alfredo Giovannelli, Silvia Codella, Gemma Viola, Daniela Diamanti, Renato Massoud, Sergio Bernardini, Massimo Pieri | 208-214 |
doi: https://doi.org/10.14740/jh1165 |
Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis | Abstract HTML PDF Suppl1 Suppl2 Suppl3 Suppl4 Suppl5 Suppl6 |
Fei Luo![]() ![]() |
215-226 |
doi: https://doi.org/10.14740/jh1169 |
Case Report
A Rare Coexistence of Multiple Myeloma and Polycythemia Vera | Abstract HTML PDF |
Alexander Landsman, Priyanka Barua, Alida Podrumar | 227-230 |
doi: https://doi.org/10.14740/jh1167 |
Cyclic Thrombocytopenia in the Setting of Intracranial Hemorrhage: A Diagnostic and Therapeutic Challenge | Abstract HTML PDF |
Ryan Sweeney, Maitreyee Rai, Harmeet Kharoud, Rama Bhagavatula, Robert Kaplan, Deep Shah | 231-235 |
doi: https://doi.org/10.14740/jh1171 |
When Lymphoma Strikes the Pancreas: A Rare Presentation of Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in a Human Immunodeficiency Virus-Positive Patient | Abstract HTML PDF |
Hehua Hannah Huang, Xin Qing![]() |
236-242 |
doi: https://doi.org/10.14740/jh1138 |